Wednesday, November 07, 2018 9:43:51 AM
That is exactly the concern.
The CEO, the same CEO appointed by the previous people who wrote and published the FAKE PR.
The road to recovery for SHMN might be long.
That FAKE PR, endorsed and approved, and written by SHMN made people lose money.
With the multi million shares volume days around 10 days before the FAKE PR, one could think it was planned.
Long road to recovery ahead indeed.......
The CEO, the same CEO appointed by the previous people who wrote and published the FAKE PR.
The road to recovery for SHMN might be long.
That FAKE PR, endorsed and approved, and written by SHMN made people lose money.
With the multi million shares volume days around 10 days before the FAKE PR, one could think it was planned.
Long road to recovery ahead indeed.......
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
